Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | CDK1 | P06493 | 2/20 | 0.33 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.33 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.33 |
| ▸ | CDK2 | P24941 | 2/20 | 0.33 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.33 |
| ▸ | MGMT | P16455 | 1/20 | 0.33 |
| ▸ | DHFR | P00374 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4241038 | 0.83 | ALDH1A1 (0.41) | ALDH1A1RXFP1 | |
| SCHEMBL5961402 | 0.81 | — | — | |
| SCHEMBL4388432 | 0.80 | ALDH1A1 (0.39) | ALDH1A1RXFP1 | |
| SCHEMBL28328648 | 0.78 | ALDH1A1 (0.46) | ALDH1A1RXFP1CDK1CCNB1CCNA2 | |
| SCHEMBL7175004 | 0.77 | TP53 (0.32) | ALDH1A1RXFP1CDK1CCNB1NPSR1 | |
| SCHEMBL31735186 | 0.77 | GRM5 (0.31) | — | |
| SCHEMBL4336356 | 0.77 | — | — | |
| SCHEMBL9363803 | 0.77 | ALDH1A1 (0.36) | ALDH1A1RXFP1 | |
| SCHEMBL8607902 | 0.76 | MAPT (0.32) | — | |
| SCHEMBL14743780 | 0.75 | ALDH1A1 (0.43) | ALDH1A1RXFP1DHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040191780-A1 | Simple and efficient tissue culture process of producing viable plants of Decalepis hamiltonii using vescicular arbuscular mycorrhizae (VAM) | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2004-09-30 | — | — | US | claimed |
| EP-4367673-A1 | METHODS OF GENERATING CORE STRANDS IN CONDITIONALLY ACTIVATABLE NUCLEIC ACID COMPLEXES | Switch Therapeutics Inc. (US) | 2024-05-15 | — | — | EP | disclosed |
| EP-4367672-A1 | METHODS OF DESIGNING CONDITIONAL-ACTIVATABLE SMALL INTERFERING RNA SENSORS | Switch Therapeutics Inc. (US) | 2024-05-15 | — | — | EP | disclosed |
| EP-4367238-A1 | METHODS OF PLACING LOCKED NUCLEIC ACIDS IN SMALL INTERFERING RNA STRANDS | Switch Therapeutics Inc. (US) | 2024-05-15 | — | — | EP | disclosed |
| CN-116617233-A | Methods of treating arenaviridae and coronaviridae viral infections | 吉利德科学公司 | 2023-08-22 | — | — | CN | disclosed |
| WO-2023070057-A1 | CONDITION-ACTIVATABLE NUCLEIC ACID CONSTRUCTS AND THEIR USES FOR TREATING NEUROLOGICAL DISEASES | SWITCH THERAPEUTICS INC. (US) | 2023-04-27 | — | — | WO | disclosed |
| CN-109776637-B | Nucleoside phosphoramidate prodrugs | 吉利德科学公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-115887465-A | Methods of treating arenaviridae and coronaviridae virus infections | 吉利德科学公司 | 2023-04-04 | — | — | CN | disclosed |
| CN-115844896-A | Methods of treating arenaviridae and coronaviridae virus infections | 吉利德科学公司 | 2023-03-28 | — | — | CN | disclosed |
| WO-2023283553-A1 | METHODS OF GENERATING CORE STRANDS IN CONDITIONALLY ACTIVATABLE NUCLEIC ACID COMPLEXES | SWITCH THERAPEUTICS INC. (US) | 2023-01-12 | — | — | WO | disclosed |
| CN-102989012-A | Monitoring and modulating hgf/hgfr activity | GEN HOSPITAL CORP | 2013-03-27 | — | — | CN | disclosed |
| CN-101189023-B | Monitoring and modulating hgf/hgfr activity | GEN HOSPITAL CORP | 2013-01-30 | — | — | CN | disclosed |
| CN-101681396-A | Glucoprotein product that limits and associated method | MOMENTA PHARMACEUTICALS INC | 2010-03-24 | — | — | CN | disclosed |
| CN-101626777-A | Immunophilin ligands and methods of modulating immunophilin and calcium channel activity | WYETH CORP | 2010-01-13 | — | — | CN | disclosed |
| US-7585851-B2 | 3′-prodrugs of 2′-deoxy-β-L-nucleosides | IDENIX PHARMACEUTICALS, INC. (US) | 2009-09-08 | — | — | US | disclosed |
| CN-101405408-A | Method for enhancing lymphatic function | GEN HOSPITAL CORP (US) | 2009-04-08 | — | — | CN | disclosed |
| CN-101189023-A | Monitoring and modulating HGF/HGFR activity | GEN HOSPITAL CORP (US) | 2008-05-28 | — | — | CN | disclosed |
| US-20040191780-A1 | Simple and efficient tissue culture process of producing viable plants of Decalepis hamiltonii using vescicular arbuscular mycorrhizae (VAM) | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2004-09-30 | — | — | US | disclosed |
| CN-1326510-A | Method for obtaining genetically modified plants, plant material and plant habitat obtainable by this method | GENESIS RES & DEV CORP LTD (NZ) | 2001-12-12 | — | — | CN | disclosed |
| US-6242257-B1 | CUTTING APICAL EXPLANT FROM GERMINATED COTTON SEEDLING, CULTURING FOR SHOOT PROLIFERATION IN MEDIUM FREE OF AUXIN AND SUCROSE, HARVESTING SHOOTS, THEN CULTURING EACH SHOOT IN SECOND MEDIUM; EFFICIENT PROCESS FOR GENETIC ENGINEERING | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2001-06-05 | — | — | US | disclosed |